Expert group consensus: prevention, diagnosis and treatment of bone loss and osteoporosis in postmenopausal breast cancer patients after aromatase inhibitor therapy.
- Author:
Xiu BING-HE
1
;
null
Author Information
1. Email: xubinghe@csco.org.cn.
- Publication Type:Journal Article
- MeSH:
Aromatase Inhibitors;
adverse effects;
therapeutic use;
Bone Density;
drug effects;
Bone Density Conservation Agents;
therapeutic use;
Breast Neoplasms;
drug therapy;
Calcium;
therapeutic use;
Diphosphonates;
therapeutic use;
Female;
Fractures, Bone;
chemically induced;
prevention & control;
Humans;
Imidazoles;
therapeutic use;
Osteoporosis, Postmenopausal;
chemically induced;
diagnosis;
prevention & control;
Postmenopause;
Vitamin D;
therapeutic use
- From:
Chinese Journal of Oncology
2013;35(11):876-879
- CountryChina
- Language:Chinese
